Delivery Order 75F40123D00021-75F40125F19007

Award Date 6/25/25
Potential Completion Date 10/31/27
Potential Value $12M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Food and Drug Administration (FDA) awarded a $9,594,482 labor hour contract to Kaiva Strategies, LLC, an 8(a) certified small business, to provide writer/editor support services to the Center for Drug Evaluation and Research (CDER) and Office of New Drugs (OND). The contract has an ultimate completion date of June 24, 2025 and was issued a notice to proceed on May 30. Kaiva Strategies is a tribally-owned, minority-owned small business based in Ivins, Utah that specializes in providing...
This is a $3,441,672.52 definitive contract awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business based in Ivins, Utah. The contract provides professional and technical support services to the FDA's Center for Devices and Radiological Health (CDRH) and is designated as an 8(a) sole source award. Kaiva Strategies holds multiple small business certifications, including 8(a) joint venture, HUBZone, and small disadvantaged...
This is a $1,298,305.44 firm-fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business based in Ivins, Utah. The contract is for the provision of two consultants and one project manager to support the FDA's professional, administrative, and consulting services requirements. The award is under the FDA's $100 million single-award Indefinite Delivery Contract (IDC) for Professional, Administrative, and...
This is a direct 8(a) sole source award from the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business located in Ivins, Utah. The $3,085,928.12 time and materials contract provides professional services to support the FDA Office of Women's Health science-related activities over a 12-month base period and four 12-month option periods, with a potential completion date of April 25, 2029. Kaiva Strategies holds several small business...
This is a 2-year, labor-hour type contract awarded by the U.S. Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business. The contract is for $354,459.18 and is to provide food ingredient and food contact materials support to the FDA's Center for Food Safety and Applied Nutrition, Office of Food Additive Safety. The contract was awarded as an 8(a) sole source set-aside, leveraging Kaiva Strategies' small business certifications. Kaiva Strategies...
This is a $176,258.28 purchase order contract awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business based in Ivins, Utah. The contract is an 8(a) sole source award to fill a temporary need for an executive assistant in the Office of the Center Director until other recruitment efforts can be identified. The contract has a period of performance through June 30, 2025 and utilizes a labor hours pricing type. Kaiva Strategies holds...
This is a federal delivery order awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business located in Ivins, Utah. The order is for $554,519.76 and provides for the services of one full-time management analyst to support the administrative operations of the Office of the Center Director with day-to-day tasks. The order is issued under Kaiva Strategies' existing $100 million Indefinite Delivery Contract (IDC) for Professional,...
This is a 1-year, labor-hour (LH) type contract for $359,086.60 awarded by the U.S. Food and Drug Administration (FDA) to Kaiva Strategies, LLC, an 8(a) certified small disadvantaged business. The contract is for regulatory support services to the FDA's Generic Drug Program, involving research and documentation to support the review of Abbreviated New Drug Applications. The contract is a direct 8(a) sole source award. Kaiva Strategies is a tribally-owned, minority-owned small business that...
This is a $1,112,508.23 delivery order contract awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business. The contract is for medical writers to support the FDA's Office of Vaccines Research and Review (OVRR). The period of performance runs through June 30, 2023. This award is part of Kaiva Strategies' larger portfolio of contracts with the FDA, including two Indefinite Delivery Contracts (IDCs) totaling over $122 million to...
This is a $1,456,269.36 Delivery Order contract awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business based in Ivins, Utah. The contract is for medical writer support services and is not set aside. Kaiva Strategies holds two significant Indefinite Delivery Contracts (IDCs) with the FDA - a $100 million single-award IDC for Professional, Administrative, and Consulting Services (PACS), and a $22 million single-award IDC for...
  • 75F40123D00021
    Indefinite Delivery Contract
  • 75F40123D00021-75F40125F19007
    Delivery Order

This is a labor hour contract awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business based in Ivins, Utah. The contract, with a ceiling value of $12,198,266.28, is for health science support services for the FDA's Center for Drug Evaluation and Research (CDER) and Office of New Drugs (OND). The contract was awarded on June 25, 2025, with a notice to proceed issued on June 17, 2025, and an ultimate completion date of October 31, 2027. This contract is part of the FDA's Professional, Administrative, and Consulting Services (PACS) Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle, which is a single-award IDIQ with a $100 million ceiling value, set aside for competitive 8(a) businesses. Kaiva Strategies also holds a separate $22 million single-award IDIQ contract with the FDA for medical writing support services. These IDIQ contracts provide the FDA with flexible mechanisms to obtain specialized expertise from Kaiva Strategies across various program offices to support the agency's critical public health missions.

Generated 6/26/25, 9:50 AM